According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM) is $46.15 B. In 2021 the company made a revenue of $46.38 B an increase over the years 2020 revenue that were of $42.51 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $46.15 B | -0.49% |
2021 | $46.38 B | 9.09% |
2020 | $42.51 B | 62.62% |
2019 | $26.14 B | 15.89% |
2018 | $22.56 B | 8.59% |
2017 | $20.77 B | 6.94% |
2016 | $19.42 B | 17.31% |
2015 | $16.56 B | 4.29% |
2014 | $15.87 B | -3.09% |
2013 | $16.38 B | -7.01% |
2012 | $17.62 B | -17.05% |
2011 | $21.24 B | 9.03% |
2010 | $19.48 B | 3.59% |
2009 | $18.80 B | -9.95% |
2008 | $20.88 B | 7.95% |
2007 | $19.34 B | 8% |
2006 | $17.91 B | -6.73% |
2005 | $19.20 B | -0.89% |
2004 | $19.38 B | -7.25% |
2003 | $20.89 B | 19.63% |
2002 | $17.46 B | -10.08% |
2001 | $19.42 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $94.94 B | 105.69% | ๐บ๐ธ USA |
![]() Novartis NVS | $51.82 B | 12.28% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $100.33 B | 117.36% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $58.05 B | 25.77% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $28.54 B | -38.17% | ๐บ๐ธ USA |
![]() Amgen AMGN | $26.32 B | -42.97% | ๐บ๐ธ USA |
![]() Sanofi SNY | $47.62 B | 3.18% | ๐ซ๐ท France |
![]() Biogen BIIB | $10.17 B | -77.96% | ๐บ๐ธ USA |
![]() Merck MRK | $59.28 B | 28.43% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $44.35 B | -3.92% | ๐ฌ๐ง UK |